Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 107

1.

Cost Effectiveness of Screening Colonoscopy Depends on Adequate Bowel Preparation Rates - A Modeling Study.

Kingsley J, Karanth S, Revere FL, Agrawal D.

PLoS One. 2016 Dec 9;11(12):e0167452. doi: 10.1371/journal.pone.0167452.

2.

Clinical Implications and Future Perspectives of Circulating Tumor Cells and Biomarkers in Clinical Outcomes of Colorectal Cancer.

Huang MY, Tsai HL, Huang JJ, Wang JY.

Transl Oncol. 2016 Aug;9(4):340-7. doi: 10.1016/j.tranon.2016.06.006. Review.

3.

The effectiveness of FOBT vs. FIT: A meta-analysis on colorectal cancer screening test.

Mousavinezhad M, Majdzadeh R, Akbari Sari A, Delavari A, Mohtasham F.

Med J Islam Repub Iran. 2016 May 9;30:366.

4.

Changing Cycle Lengths in State-Transition Models: Challenges and Solutions.

Chhatwal J, Jayasuriya S, Elbasha EH.

Med Decis Making. 2016 Nov;36(8):952-64. doi: 10.1177/0272989X16656165.

PMID:
27369084
5.

Cost-effectiveness of alternative colonoscopy surveillance strategies to mitigate metachronous colorectal cancer incidence.

Erenay FS, Alagoz O, Banerjee R, Said A, Cima RR.

Cancer. 2016 Aug 15;122(16):2560-70. doi: 10.1002/cncr.30091.

PMID:
27248907
6.

Designing Colorectal Cancer Screening Decision Support: A Cognitive Engineering Enterprise.

Militello LG, Saleem JJ, Borders MR, Sushereba CE, Haverkamp D, Wolf SP, Doebbeling BN.

J Cogn Eng Decis Mak. 2016 Mar;10(1):74-90.

7.

Colorectal Cancer Screening Based on Age and Gender: A Cost-Effectiveness Analysis.

Wong MC, Ching JY, Chan VC, Lam TY, Luk AK, Wong SH, Ng SC, Ng SS, Wu JC, Chan FK, Sung JJ.

Medicine (Baltimore). 2016 Mar;95(10):e2739. doi: 10.1097/MD.0000000000002739.

8.

Validation of Models Used to Inform Colorectal Cancer Screening Guidelines: Accuracy and Implications.

Rutter CM, Knudsen AB, Marsh TL, Doria-Rose VP, Johnson E, Pabiniak C, Kuntz KM, van Ballegooijen M, Zauber AG, Lansdorp-Vogelaar I.

Med Decis Making. 2016 Jul;36(5):604-14. doi: 10.1177/0272989X15622642.

PMID:
26746432
10.

Colon Capsule Endoscopy for the Detection of Colorectal Polyps: An Economic Analysis.

Palimaka S, Blackhouse G, Goeree R.

Ont Health Technol Assess Ser. 2015 Jul 1;15(15):1-43.

11.

The comparative cost-effectiveness of colorectal cancer screening using faecal immunochemical test vs. colonoscopy.

Wong MC, Ching JY, Chan VC, Sung JJ.

Sci Rep. 2015 Sep 4;5:13568. doi: 10.1038/srep13568.

12.

Derivation and Validation of a Scoring System to Stratify Risk for Advanced Colorectal Neoplasia in Asymptomatic Adults: A Cross-sectional Study.

Imperiale TF, Monahan PO, Stump TE, Glowinski EA, Ransohoff DF.

Ann Intern Med. 2015 Sep 1;163(5):339-46. doi: 10.7326/M14-1720.

13.

Choosing the optimal method in programmatic colorectal cancer screening: current evidence and controversies.

Castells A.

Therap Adv Gastroenterol. 2015 Jul;8(4):221-33. doi: 10.1177/1756283X15578610. Review.

14.

Cost-Savings to Medicare From Pre-Medicare Colorectal Cancer Screening.

Goede SL, Kuntz KM, van Ballegooijen M, Knudsen AB, Lansdorp-Vogelaar I, Tangka FK, Howard DH, Chin J, Zauber AG, Seeff LC.

Med Care. 2015 Jul;53(7):630-8. doi: 10.1097/MLR.0000000000000380.

15.

A prediction model for colon cancer surveillance data.

Good NM, Suresh K, Young GP, Lockett TJ, Macrae FA, Taylor JM.

Stat Med. 2015 Aug 15;34(18):2662-75. doi: 10.1002/sim.6500.

16.

Incremental benefits of screening colonoscopy over sigmoidoscopy in average-risk populations: a model-driven analysis.

Jeon J, Meza R, Hazelton WD, Renehan AG, Luebeck EG.

Cancer Causes Control. 2015 Jun;26(6):859-70. doi: 10.1007/s10552-015-0559-7.

17.

Estimating development cost of an interactive website based cancer screening promotion program.

Lairson DR, Chung TH, Smith LG, Springston JK, Champion VL.

Eval Program Plann. 2015 Jun;50:56-62. doi: 10.1016/j.evalprogplan.2015.01.009.

18.

The costs of nosocomial resistant gram negative intensive care unit infections among patients with the systemic inflammatory response syndrome- a propensity matched case control study.

Vasudevan A, Memon BI, Mukhopadhyay A, Li J, Tambyah PA.

Antimicrob Resist Infect Control. 2015 Feb 2;4(1):3. doi: 10.1186/s13756-015-0045-8.

19.

Development of new non-invasive tests for colorectal cancer screening: the relevance of information on adenoma detection.

Haug U, Knudsen AB, Lansdorp-Vogelaar I, Kuntz KM.

Int J Cancer. 2015 Jun 15;136(12):2864-74. doi: 10.1002/ijc.29343.

20.

Guaiac faecal occult blood test performance at initial and repeat screens in the English Bowel Cancer Screening Programme.

Kearns B, Whyte S, Chilcott J, Patnick J.

Br J Cancer. 2014 Oct 28;111(9):1734-41. doi: 10.1038/bjc.2014.469.

Items per page

Supplemental Content

Support Center